False Claims Act Update & Alert
Taxpayers Against Fraud Education Fund | Washington, D.C. | WWW.TAF.ORG November 01, 2005
		Sign Up for this FREE Newsletter n Previous Newsletters n TAF Home Page n About TAF-EF n The False Claims Act n Email editor Please take a moment to forward this FREE electronic newsletter to others that might be interested!
			King Pharmaceuticals Settles for $124 Million King Pharmaceuticals has settled a False Claims Act case for $125 million. The case involves violation of Medicaid prescription drug "best price" regulations and the underpayment of rebates for the drugs Altace, Aplisol, Lorabid, and Fluogen. King Pharmaceutical was giving price breaks to pharmacy benefit management companies (PBMs) that it was not giving to the U.S. Government.   >> To read more
			Fast Fact:  Settlements in 13 drug manufacturing cases since 2001 total more than $3.25 billion, and the U.S. Department of Justice says more than 150 prescription drug cases are now under investigation.
			Hunt Valve Settles for $13.2 M Northrop Grumman, General Dynamics Electric Boat and other defendants have agreed to pay a total of $13.2 million to settle a whistleblower lawsuit accusing the companies of failing to stop obvious quality and fraud problems at Hunt Valve, a key maker of parts used in nuclear submarines and nuclear waste storage tanks. Tina Marie and William Gonter were the relators in the case, and were awarded a 29% relator's share. >> To read more
			Fluor Settles for $12.5 M Fluor, a large government-services company, has settled a False Claims Act lawsuit charging the company with knowingly over billing the government under several cost-reimbursable contracts  between 1995 and 1998. This is Fluor's second False Claims Act settlement.  >> To read more
			Senate Finance on FCA The Senate Finance Committee has voted out legislation that would create incentives for states to pass Medicaid False Claims Act legislation. The same bill would also require companies doing more than a $1 million worth of business with Medicaid to educate their employees about the provisions of the Federal False Claims Act.  >> To read sections 6023-6024 of S. 1932
			Heart Device Firms Subpoenaed Three manufacturers of heart pacemakers and defibrillators have been subpoenaed by the U.S. Attorney's Office in Boston.  The firms are St. Jude Medical Inc., Medtronic Inc. and Guidant Corp. Since June, Guidant has recalled or issued warnings about 88,000 heart defibrillators and almost 200,000 pacemakers because of reported malfunctions. >> To read more